Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-291.89%
operating margin TTM
-291.03%
revenue TTM
1.96 Million
revenue per share TTM
0.69$
valuation ratios | |
|---|---|
| pe ratio | -0.32 |
| peg ratio | -0.01 |
| price to book ratio | -0.62 |
| price to sales ratio | 0.14 |
| enterprise value multiple | 0.21 |
| price fair value | -0.62 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -291.03% |
| pretax profit margin | -290.84% |
| net profit margin | -291.89% |
| return on assets | -166.89% |
| return on equity | 543.83% |
| return on capital employed | -2522.12% |
liquidity ratio | |
|---|---|
| current ratio | 1.05 |
| quick ratio | 1.05 |
| cash ratio | 0.94 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 0.00 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.27 |
| debt equity ratio | -1.48 |
| long term debt to capitalization | 13.97 |
| total debt to capitalization | 3.06 |
| interest coverage | -8.91 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.00 |
| cash per share | 0.99 |
| operating cash flow per share | 0.00 |
| free cash flow operating cash flow ratio | 0.00 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) reported earnings?
ASLAN Pharmaceuticals Limited (ASLN) published its most recent earnings results on 31-03-2024.
What is ASLAN Pharmaceuticals Limited's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ASLAN Pharmaceuticals Limited (NASDAQ:ASLN)'s trailing twelve months ROE is 543.83%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ASLAN Pharmaceuticals Limited (ASLN) currently has a ROA of -166.89%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ASLN's net profit margin stand at?
ASLN reported a profit margin of -291.89% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ASLN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.05 in the most recent quarter. The quick ratio stood at 1.05, with a Debt/Eq ratio of -1.48.